Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
09/2010
09/01/2010CN101816708A Chinese medicinal composition for curing rheumatism and preparation method thereof
09/01/2010CN101816692A Extraction method of chrysanthemum saponin
09/01/2010CN101816688A Chinese medicinal composition for treating anemopyretic cold and preparation method thereof
09/01/2010CN101816687A Method for extracting mangosteen pericarp anthocyanin and application thereof in preparing anti-inflammatory drugs
09/01/2010CN101816682A Quality detection method of paracetamol,caffeine, artificial cow-bezoar and amantadine hydrochloride tablets
09/01/2010CN101816668A Medical application of 2-O-alpha-L-rhamnose-4,6,4'-trihydroxybenzophenone
09/01/2010CN101816643A Medicament composition containing diclofenac sodium and acetaminophen
09/01/2010CN101816637A Leflunomide tablet preparation and preparation method thereof
09/01/2010CN101816626A Pharmaceutical compositions and dosage forms of thalidomide
09/01/2010CN101816470A Magnetic medicament waist belt and preparation method thereof
09/01/2010CN101254284B Rheumatism treating medicine combination, preparation and quality control method
09/01/2010CN101245098B Antimicrobial antiphlogistic antagonism polypeptide simulating MD2
09/01/2010CN101181557B Chinese medicine composition for curing ankylosing spondylitis, rheumatism and rheumatoid as well as method of making the same
09/01/2010CN101181011B Chinese herbal medicine feedstuff additive-summer quiet powder and preparation method as well as application thereof
09/01/2010CN101099846B Detumescence pain-relieving Babu plaster and preparing method
09/01/2010CN101023996B Chinese medicine for treating exogenous epidemic disease and anemopyretic cold
08/2010
08/31/2010US7786321 Compounds of the N-acylamino amide family compositions comprising them and uses thereof
08/31/2010US7786305 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
08/31/2010US7786177 Phenylalanine enamide derivatives
08/31/2010US7786172 percutaneously; cyclical mastalgia; may be formulated in a hydroalcoholic gel or an alcoholic solution
08/31/2010US7786160 Combination of selected analgesics and COX-II inhibitors
08/31/2010US7786135 Substituted pyrroline kinase inhibitors
08/31/2010US7786123 Indolylmaleimide derivatives
08/31/2010US7786042 Fluridone as an anti-inflammatory agent
08/31/2010US7785838 Variants of mammalian prolactin, prolactin receptor antagonists, and methods of use
08/31/2010US7785833 Methods and means for producing proteins with predetermined post-translational modifications
08/31/2010US7785819 Diagnosis of autoimmune disease; generate solid support, incubate with fluid sample, detect preferential antigens, compare to control, evaluate for autoimmune diseases
08/31/2010US7785804 Mammalian CX3C chemokine antibodies
08/31/2010US7785599 Albumin fusion proteins
08/31/2010CA2574600C Pyridine derivatives
08/31/2010CA2462008C Systems, methods and apparatuses for manufacturing dosage forms
08/26/2010WO2010096677A2 Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof
08/26/2010WO2010095714A1 Novel compounds and binding inhibitors, anti-allergic agents, anti-asthmatic agents and anti-inflammatory agents
08/26/2010WO2010095706A1 Novel anti-inflammatory compounds
08/26/2010WO2010095663A1 Fused heterocyclic ring compound
08/26/2010WO2010095463A1 Immunopotentiating composition and process for producing same
08/26/2010WO2010095462A1 Novel compounds comprising a 3-(5-alkoxypyrimidin-2-yl) pyrimidin-4(3h)-one structure and drugs that comprise same
08/26/2010WO2010095270A1 Anti-human α9 integrin antibody and use thereof
08/26/2010WO2010095227A1 Novel compound, and binding inhibitor, anti-allergic agent, anti-asthma agent and anti-inflammatory agent
08/26/2010WO2010094956A1 Triazolopyridine derivatives as p38 map kinase inhibitors
08/26/2010WO2010094721A1 Piperidin-pyrimidine derivatives as antagonists of histamine h4 receptor
08/26/2010WO2010094643A1 Quinoline derivatives and their uses for rhinitis and urticaria
08/26/2010US20100217045 Composition to enhance the bioavailability of curcumin
08/26/2010US20100216882 Aspirin-triggered lipid mediators
08/26/2010US20100216871 Use of compounds having ccr antagonism
08/26/2010US20100216865 MicroRNA COMPOSITIONS IN THE TREATMENT OF VEGF-MEDIATED DISORDERS
08/26/2010US20100216847 Nornicotine for the treatment of pain
08/26/2010US20100216843 Novel salt 628
08/26/2010US20100216833 Tetrahydrocarbazoles and derivatives
08/26/2010US20100216830 Oral Composition Comprising A Cooling Agent
08/26/2010US20100216823 Spirocyclic Derivatives
08/26/2010US20100216819 Thiazolopyrimidines for Use in Therapy
08/26/2010US20100216815 N-substituted oxindoline derivatives as calcium channel blockers
08/26/2010US20100216812 Cyclopropyl Amide Derivatives
08/26/2010US20100216801 Thiazolones for use as pi3 kinase inhibitors
08/26/2010US20100216790 Imidazopyridine-derivatives as inducible no-synthase inhibitors
08/26/2010US20100216786 New compounds
08/26/2010US20100216785 Pharmaceutical compositions
08/26/2010US20100216781 mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
08/26/2010US20100216780 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use
08/26/2010US20100216778 Pain remedy containing rock inhibitor
08/26/2010US20100216768 N-substituted azaindoles and methods of use
08/26/2010US20100216763 Heteroaryl Amide Derivatives
08/26/2010US20100216762 Agonists and Antagonists of the S1P5 Receptor, and Methods of Use Thereof
08/26/2010US20100216760 Novel compounds as cannabinoid receptor ligands
08/26/2010US20100216756 Compositions and methods for suppressing endometrial proliferation
08/26/2010US20100216754 Compositions for the treatment of inflammation of the gastrointestinal tract
08/26/2010US20100216748 Pyrrole Derivatives and Their Methods of Use
08/26/2010US20100216739 Method of promoting muscle tissue repair
08/26/2010US20100216724 Use of fibronectin fragment (196-203 ) as a therapeutic agent
08/26/2010US20100216722 Use of the peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys as a therapeutic agent
08/26/2010US20100215787 Composition For The Treatment Of Gastrointestinal Diseases
08/26/2010US20100215786 Morinda citrifolia enhanced lip treatment
08/26/2010US20100215776 Method of treating a sore throat
08/26/2010US20100215765 Antimicrobial Composition and a Method of Controlling Contamination and Infection Using Said Composition
08/26/2010US20100215759 Pharmaceutical compounds
08/26/2010US20100215741 Pharmaceutical compounds
08/26/2010US20100215736 Oral dosage form providing fast adsorption of drug
08/26/2010US20100215676 Kdr peptides and vaccines comprising the same
08/26/2010US20100215673 Method for treating inflammation and controlled-release material capable of providing same
08/26/2010US20100215666 Il-17 antagonistic antibodies
08/26/2010US20100215664 Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6 -mediated signalling
08/26/2010US20100215661 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100215653 Methods of treating neoplastic, autoimmune and inflammatory diseases
08/26/2010US20100215652 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100215646 Immunostimulatory activity of palindromic immune modulatory oligonucleotides (imo) containing different lengths of palindromic segments
08/26/2010US20100215645 determining increased risk for developing positive autoantibody rheumatoid factor (RF+) Rheumatoid Arthritis (RA) in human by testing nucleic acid from the human to detect the nucleotide content of a single nucleotide polymorphism (SNP) at position 101 of any of SEQ ID NOS:10,916-49,582 and 50,231
08/26/2010US20100215631 Anti-inflammatory composition comprising glycine and lactoferrin and the use thereof
08/26/2010US20100215624 Pharmaceutical Compositions for Treating Rheumatoid Arthritis Comprising Semi-Mature Dendritic Cell
08/26/2010US20100215614 Enterostatin as Inhibitor of Angiogenesis
08/26/2010US20100215603 Body Surface Protecting Composition
08/26/2010US20100215574 Process for producing an injectable medicament preparation
08/26/2010US20100215572 Methods of treatment using ldcam
08/26/2010CA2786891A1 Immunopotentiating composition and process for producing same
08/26/2010CA2777743A1 Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof
08/26/2010CA2753280A1 Anti-human .alpha.9 integrin antibody and use thereof
08/26/2010CA2752693A1 Triazolopyridine derivatives as p38 map kinase inhibitors
08/25/2010EP2221377A1 Oligonucleotide compositions with enhanced efficiency
08/25/2010EP2221047A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
08/25/2010EP2220073A1 Pyridazinone derivatives as parp inhibitors
1 ... 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 ... 1272